Published in Drug Des Devel Ther on November 09, 2015
The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes (2006) 3.00
Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol (2007) 2.99
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol (1996) 2.64
Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses' Health Study. Diabetes Care (2007) 2.33
Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci U S A (1992) 2.09
Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care (2001) 1.95
Diabetic retinopathy. Diabetes Care (2003) 1.61
Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]-gingerol, [10]-gingerol and [6]-shogaol. J Ethnopharmacol (2009) 1.60
[6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo. Biochem Biophys Res Commun (2005) 1.39
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Circulation (2014) 1.32
[6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. J Nutr Biochem (2007) 1.24
Cardiovascular effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways. Vascul Pharmacol (2005) 1.18
Impairment of both nitric oxide-mediated and EDHF-type relaxation in small mesenteric arteries from rats with streptozotocin-induced diabetes. Br J Pharmacol (2011) 1.16
Enhanced contractile responses of arteries from diabetic rats to alpha 1-adrenoceptor stimulation in the absence and presence of extracellular calcium. J Cardiovasc Pharmacol (1990) 1.15
Quercetin protects against diabetes-induced exaggerated vasoconstriction in rats: effect on low grade inflammation. PLoS One (2013) 1.07
Ginger: history and use. Adv Ther (1998) 1.05
Evaluation of alpha-glucosidase, alpha-amylase and protein glycation inhibitory activities of edible plants. Int J Food Sci Nutr (2010) 1.03
Early diabetic nephropathy in type 1 diabetes: new insights. Curr Opin Endocrinol Diabetes Obes (2014) 0.98
[6]-Gingerol isolated from ginger attenuates sodium arsenite induced oxidative stress and plays a corrective role in improving insulin signaling in mice. Toxicol Lett (2012) 0.94
Anti-platelet aggregation and vasorelaxing effects of the constituents of the rhizomes of Zingiber officinale. Molecules (2012) 0.94
Pentoxifylline alleviates vascular impairment in insulin resistance via TNF-α inhibition. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.93
Arginase inhibition alleviates hypertension associated with diabetes: effect on endothelial dependent relaxation and NO production. Vascul Pharmacol (2012) 0.90
The effect of vanadyl treatment on vascular responsiveness of streptozotocin-diabetic rats. Diabetologia (1994) 0.89
Inhibition of human endothelial cell nitric oxide synthesis by advanced glycation end-products but not glucose: relevance to diabetes. Clin Sci (Lond) (2005) 0.85
Exploring mechanisms of diabetes-related macrovascular complications: role of methylglyoxal, a metabolite of glucose on regulation of vascular contractility. J Pharmacol Sci (2012) 0.85
6-gingerol ameliorated doxorubicin-induced cardiotoxicity: role of nuclear factor kappa B and protein glycation. Cancer Chemother Pharmacol (2012) 0.84
Impaired vasoconstriction to endothelin 1 in patients with NIDDM. Diabetes (1996) 0.82
Duration-dependent attenuation of acetylcholine--but not histamine--induced relaxation of the aorta in diabetes mellitus. Gen Pharmacol (1993) 0.79
Attenuated alpha-adrenoceptor-mediated arterial and venous constrictions in rat models of diabetes. Eur J Pharmacol (2010) 0.78
Renovascular beta adrenergic hypersensitivity and hyperinsulinemia in rats with dietary-induced obesity. J Pharmacol Exp Ther (1990) 0.78
Contractile responses of diabetic rat aorta to phenylephrine at different stages of diabetic duration. Acta Pharmacol Sin (2001) 0.78
Antihepatotoxic effect of marrubium vulgare and withania somnifera extracts on carbon tetrachloride-induced hepatotoxicity in rats. J Basic Clin Pharm (2010) 0.89
Geraniol improves the impaired vascular reactivity in diabetes and metabolic syndrome through calcium channel blocking effect. J Diabetes Complications (2016) 0.78
Protective effect of zingerone on increased vascular contractility in diabetic rat aorta. Eur J Pharmacol (2016) 0.77
Solid lipid nanoparticles loaded with iron to overcome barriers for treatment of iron deficiency anemia. Drug Des Devel Ther (2015) 0.75
Geraniol alleviates diabetic cardiac complications: Effect on cardiac ischemia and oxidative stress. Biomed Pharmacother (2017) 0.75
Cardioprotection by 6-gingerol in diabetic rats. Biochem Biophys Res Commun (2016) 0.75